ReTrans Enterprise
AI-powered literature surveillance for pharmacovigilance. Automates regulatory compliance with unparalleled accuracy. Significantly reduces cost and time in drug safety monitoring.
Know More
ALWIS
Pioneering AI-Driven Drug Safety for a Healthier Tomorrow
At the forefront of drug development and innovation, we harness cutting-edge Next-Gen technologies to revolutionize drug safety monitoring and management.
A team of specialists, passionate about innovation, harnessing AI, NLP, and ML to revolutionise drug safety monitoring and management.
Healthcare systems today amass extensive data from diverse sources and languages. Medical AI, NLP, and ML technologies transform this data into structured formats, simplifying drug safety monitoring and enhancing business outcomes. These advancements enable analysis of vast datasets from Electronic Health Records, clinical trials, and social media to identify potential adverse drug events. Furthermore, generative AI and large language models empower pharmacovigilance professionals to navigate complex regulatory landscapes efficiently. Our products ensure PV processes remain compliant with the latest standards, streamlining data-driven decision-making and improving operational efficiency in drug safety monitoring.
0
+
Years in business
0
+
Years of Platform specialists
0
%
Increased Project Efficiency
+
0
%
Accuracy
Our Platforms
Our Full Range of Modern Digital Platforms
Our Products
Host of Products from our ZiSmart Platform
ReTrans:Extension
Browser plugin for pharmacovigilance. Analyzes web content for safety data, identifies ICSRs, and integrates with global databases. Supports multi-language translation for enhanced global compliance.
